Free tool
FAERS Monitor: Prevacid 24 Hr
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 022327 or its brand name (Prevacid 24 Hr, Lansoprazole). Reports on generic versions are filed under their own applications.
Reports
125,091
Serious
115,872
93% of reports
Hospitalization
52,262
Death reported
15,413
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- chronic kidney disease17,847
- acute kidney injury11,658
- renal failure7,773
- diarrhoea6,776
- renal injury6,174
- dyspnoea6,079
- off label use6,074
- nausea5,838
- end stage renal disease5,666
- fatigue5,394
- vomiting5,323
- malaise4,848
- headache4,820
- pyrexia4,611
- dizziness4,177
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 1,299 |
| 2005 | 1,407 |
| 2006 | 1,111 |
| 2007 | 1,295 |
| 2008 | 1,663 |
| 2009 | 1,691 |
| 2010 | 1,934 |
| 2011 | 2,729 |
| 2012 | 3,421 |
| 2013 | 2,970 |
| 2014 | 3,516 |
| 2015 | 4,953 |
| 2016 | 6,295 |
| 2017 | 5,665 |
| 2018 | 15,384 |
| 2019 | 17,278 |
| 2020 | 8,898 |
| 2021 | 7,878 |
| 2022 | 7,149 |
| 2023 | 7,650 |
| 2024 | 8,173 |
| 2025 | 7,450 |
| 2026 | 5,281 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,929,068 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| end stage renal diseaseSignal | 5,666 | 75.3 | 73.0 | 286,637 |
| chronic kidney diseaseSignal | 17,847 | 51.3 | 50.5 | 676,015 |
| renal injurySignal | 6,174 | 43.8 | 42.6 | 205,013 |
| acute kidney injurySignal | 11,658 | 13.8 | 13.5 | 128,602 |
| renal failureSignal | 7,773 | 10.4 | 10.2 | 62,499 |
| pyrexiaSignal | 4,611 | 2.3 | 2.2 | 3,238 |
| vomiting | 5,323 | 1.9 | 1.9 | 2,348 |
| malaise | 4,848 | 1.9 | 1.8 | 1,975 |
| dyspnoea | 6,079 | 1.8 | 1.8 | 2,258 |
| diarrhoea | 6,776 | 1.8 | 1.7 | 2,331 |
| dizziness | 4,177 | 1.4 | 1.4 | 509 |
| headache | 4,820 | 1.3 | 1.3 | 331 |
| nausea | 5,838 | 1.2 | 1.2 | 284 |
| off label use | 6,074 | 1.2 | 1.1 | 151 |
| fatigue | 5,394 | 1.2 | 1.1 | 131 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.